VivaQuant is a digital health care company providing remote cardiac monitoring services to clinics and hospitals under the Rhythm Express brand. The company's highly differentiated mobile cardiac telemetry (MCT) wearable, the RX-1 mini, enables near real-time observation of a patient's heart rhythm and can be comfortably worn for up to 30 days. The mini was designed from the ground up to provide the trifecta of wearables - a device that is easy to wear, easy to use, and provides accurate diagnostic data. The mini contains proprietary noise cancelling algorithms that result in high-clarity ECGs, and our proprietary wavelet analytics provide near-perfect identification of cardiac arrhythmias and facilitate fast diagnosis. We provide 24/7/365 oversight of incoming patient data from the mini, where millions of heart beats are translated into actionable information that physicians can use as an aid in diagnosis and establishing life-saving care plans for patients.
VivaQuant, Inc. Named Finalist for 2021 Tekne Awards
October 26, 2021 Read more >
VivaQuant Introduces Smallest One-Piece Mobile Cardiac Telemetry Device
January 28th, 2021 Read more >
Minneapolis Star Tribune: VivaQuant is making an intriguing bet on equity crowdfunding
May 19th, 2019 Read more >
VivaQuant Receives FDA 510k Clearance for its RX-1 Rhythm Express Arrhythmia Device
April 30th, 2019 Read more >
VivaQuant inks collaboration with FDA to improve accuracy of drug cardiac safety assessment
October 2018 Read more >
VivaQuant technology shows promise for improving drug safety assessment accuracy
June 2018 Read more >
Meet VivaQuant at the Society of Toxicology 2018 in San Antonio
March 12-14, 2018 Read more >
LIVE WEBINAR: Improving Preclinical and Clinical Regulatory Submissions Through Enhanced ECG Interval and Arrhythmia Assessment
March 1st, 2018 Read more >
VivaQuant Rhythm Express software demonstrates improved accuracy of cardiac safety assessment markers
December 2017 Read more >
VivaQuant and DSI Announce Agreement
September 2017 Read more >
ECG Services
VivaQuant provides continuous beat-to-beat analysis services for ambulatory ECGs from preclinical and clinical research studies. Services include restitution analysis, predictive modeling, and complex statistics.
ECG Analysis Software
VivaQuant AE-1010 software for arrhythmia and beat-to-beat interval analysis of preclinical ECGs is fast, accurate, easy to learn, and easy to validate - saving you time and money. Process a 24-hour recording in 10-20 seconds.
Technology Licensing
VivaQuant licenses MDSP technology for select fields of use and is available for both Windows PC platforms and ultra-low-power ARM Cortex embedded platforms for heart rate measurement and arrhythmia detection.
© 2020 VivaQuant, Inc. | Sitemap